Immunocore

Immunocore

Primary Menu

  • About us
    • Management Team
    • Board of Directors
    • Partners
  • Our science
    • Pipeline
    • Publications
    • Scientific Advisory Board
  • Our therapy areas
    • Oncology
    • Infectious Diseases
    • Autoimmune and Inflammation Diseases
  • For patients
  • Investors/Media
  • News
  • Careers
  • Contact us

Primary Menu

  • About us
  • Our science
  • Our therapy areas
  • For patients
  • Investors/Media
  • News
  • Careers
  • Contact us
  1. Home
  2. /
  3. News

News

  • 5 April 2017

    Immunocore Publishes Gender Pay Report
  • 28 February 2017

    Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference
  • 1 December 2016

    Immunocore wins Financing Deal of the Year at the 12th Annual SCRIP Awards 2016
  • 9 November 2016

    Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress
  • 12 October 2016

    Immunocore Appoints Paul Fry as Chief Financial Officer
  • 12 September 2016

    Immunocore Ranked in the Sunday Times Hiscox Tech Track 100
  • 7 September 2016

    Immunocore Wins Private UK Life Science Company of the Year at Biotech and Money Assembly and Awards.
  • 8 June 2016

    Immunocore’s ImmTAV shown to redirect the immune system to kill HIV-infected cells from patients treated with antiretroviral therapy
  • 6 June 2016

    Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting
  • 30 March 2016

    Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next →

Sign up to receive news email alerts

News archive
  • Show all
  • 2021 (8)
  • 2020 (8)
  • 2019 (13)
  • 2018 (10)
  • 2017 (13)
  • 2016 (11)
  • 2015 (20)
  • 2014 (6)
  • 2013 (11)
  • 2012 (3)
  • 2011 (1)
  • 2010 (4)
  • 2009 (1)
  • 2008 (1)

Immunocore

Immunocore
  • About us
  • Our science
  • Our therapy areas
  • For patients
  • Investors/Media
  • News
  • Careers
  • Contact us
  • Privacy and Social Media Guidelines
  • Cookies
  • Payments and Disclosures
  • Clinical trials

©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd